Loading organizations...

§ Venture Capital · 270 Peachtree Street NW, Suite 2200 | Atlanta, Georgia 30303
GRA Venture Fund is a company.
Key people at GRA Venture Fund.
GRA Venture Fund operates as a distinctive public-private venture capital fund, strategically investing in research-driven, Georgia-based startup companies. The fund specifically targets high-potential enterprises emerging from advanced scientific and technological research within Georgia's university system and innovation programs. Its approach involves providing pivotal early-stage capital while actively supporting portfolio companies through various developmental phases.
The Georgia Research Alliance established GRA Venture Fund in 2009, initiating it with an evergreen investment from the State of Georgia. This foundational insight recognized the need for a dedicated partner to bridge the gap between groundbreaking academic research and successful market commercialization. The fund was conceived to ensure promising startups received crucial investment and strategic guidance, helping them attract further external venture capital and achieve sustainable growth.
The fund's portfolio primarily comprises research-based startups within Georgia, whom it serves as a long-term strategic partner. GRA Venture Fund aims to propel the development and expansion of these companies by identifying co-investors, offering expert counsel to leadership, and connecting them with an extensive network of business leaders. This holistic vision ultimately strengthens Georgia’s entrepreneurial ecosystem and translates academic innovation into viable commercial ventures.
GRA Venture Fund is a public‑private, Georgia‑based venture capital fund that provides early‑stage equity capital and operational support to research‑driven startups spun out of Georgia universities, leveraging GRA’s venture development pipeline and state match funding to accelerate commercialization of technology and life‑science innovations[2][3]. GRA Venture Fund’s mission focuses on moving university discoveries to market by combining catalytic state investment with private capital and hands‑on counsel; its investment philosophy emphasizes funding research‑based, high‑potential companies in technology, life sciences, manufacturing, agriculture and information‑related ventures where the Fund’s university network and advisory resources add measurable de‑risking value[1][6].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: GRA Venture Fund occupies a niche between state economic development and private venture capital — using matched public dollars, university pipeline advantages and hands‑on support to de‑risk and scale research‑based startups in Georgia, with the potential to materially grow the state’s innovation economy if follow‑on capital and exit outcomes continue to improve[2][1][4].
Key people at GRA Venture Fund.
GRA Venture Fund has 5 tracked investments across 5 companies. The latest tracked deal is $4.0M Seed in Altesa in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 10, 2022 | Altesa | $4.0M Seed | Pitango Venture Capital | — |
| Feb 1, 2022 | Codoxo | $5.0M Series B | QED Investors | Alumni Ventures, Brewer Lane Ventures, Flourish Ventures, Flyover Capital, NextView Ventures, Sempervirens Venture Capital, Viola Ventures, Ansaf Kareem, Mark Casady, 111 West Capital, Michael Graninger, Spider Capital |
| Nov 1, 2021 | Antios Therapeutics | $75.0M Series B | Epiq Capital Group, Craig Gordon | Domain Associates, Pontifax Venture Capital, Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health, Avego Bioscience Capital, CAM Capital, Delos Capital, Granite Point Capital, Heartland Healthcare Capital, Lifesci Venture Partners, Lumira Ventures, RA Capital Management, Sixty Degree Capital, Soleus Capital |
| Jul 20, 2017 | Carbice Corporation | $1.5M Seed | GRA Venture Fund, TechSquare Labs | — |
| Sep 1, 2012 | Urjanet | $4.0M Series B | — | Grotech Ventures, TCV, Imlay Investments |